Schedule 13G ownership disclosure

Indivior Pharmaceuticals Inc

Security class unavailable · CUSIP: 04546C106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,541,929
Percent of class
8.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-000569
Form type
SC 13G
Filer
Assertio Holdings, Inc.
CIK
CIK 1808665
Filed
Jan 27, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub